- Report
- March 2024
- 190 Pages
Global
From €3226EUR$3,374USD£2,765GBP
€3585EUR$3,749USD£3,072GBP
- Report
- February 2024
- 200 Pages
Global
From €4781EUR$5,000USD£4,097GBP
- Report
- March 2024
- 194 Pages
Global
From €5212EUR$5,450USD£4,466GBP
- Report
- June 2023
- 143 Pages
Global
From €2390EUR$2,499USD£2,048GBP
- Report
- February 2024
- 191 Pages
Global
From €3442EUR$3,600USD£2,950GBP
- Report
- February 2024
- 150 Pages
Global
From €4064EUR$4,250USD£3,482GBP
- Report
- April 2023
- 125 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- April 2023
- 114 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4733EUR$4,950USD£4,056GBP
- Report
- October 2022
- 140 Pages
Global
From €2381EUR$2,490USD£2,040GBP
- Report
- September 2018
- 115 Pages
Global
From €3046EUR$3,185USD£2,610GBP
€4351EUR$4,550USD£3,728GBP
- Clinical Trials
- February 2020
- 106 Pages
Global
From €1912EUR$2,000USD£1,639GBP
- Clinical Trials
- September 2022
- 70 Pages
Global
From €1434EUR$1,500USD£1,229GBP
- Clinical Trials
- June 2022
- 70 Pages
Global
From €1434EUR$1,500USD£1,229GBP
- Report
- January 2022
- 200 Pages
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,237GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,237GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,237GBP
- Clinical Trials
- February 2020
- 106 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Drug Pipelines
- January 2019
- 60 Pages
Global
From €1912EUR$2,000USD£1,639GBP
The Liver Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat a variety of liver diseases, including hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly used drugs include antivirals, immunosuppressants, and antifibrotics. In addition, some drugs are used to reduce the risk of liver cancer.
The Liver Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Other companies include Bristol-Myers Squibb, AstraZeneca, and Roche. Show Less Read more